CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of RNA-sequence grants
4.1.2. Rapid growth in precision medicine
4.1.3. Advantages of RNA-sequence over microarray technology
4.1.4. Technological advancements in RNA-sequence products
4.2. Market Restraints & Challenges
4.2.1. Standardization concerns of RNA-sequence in diagnostic testing
4.2.2. Storage & interpretation of sequencing data
4.3. Market Opportunities
4.3.1. Increasing applications of RNA-sequence in research
4.3.2. Demand for cancer research centres.
CHAPTER 5 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY TECHNOLOGY
5.1. Introduction
5.2. Nano pore sequencing
5.3. Single-molecule real-time sequencing
5.4. Sequencing by synthesis
5.5. Ion semiconductor sequencing
CHAPTER 6 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY PRODUCT & SERVICE
6.1. Introduction
6.1.1. Sample Preparation
6.1.1.1. Sample Preparation, By Workflow Step
6.1.1.1.1. Fragmentation, End Repair, and Size Selection
6.1.1.1.2. Library Preparation and Target Enrichment
6.1.1.1.3. Quality Control
6.1.1.2. Sample Preparation, By Method
6.1.1.2.1. Manual Sample Preparation
6.1.1.2.2. Microfluidic Sample Preparation
6.1.1.2.3. Robotic Liquid Handling Sample Preparation
6.1.2. Sequencing Platforms and Consumables
6.1.3. Sequencing Services
6.1.4. Data Analysis, Storage, and Management
CHAPTER 7 GLOBAL NGS-BASED RNA SEQUENCING MARKET – BY APPLICATION
7.1. Introduction services
7.2. Expression profiling analysis
7.3. Small RNA sequencing
7.4. De novo transcriptome assembly
7.5. Variant calling and transcriptome epigenetics
CHAPTER 8 GLOBAL NGS-BASED RNA SEQUENCING MARKET - BY END USER
8.1. Introduction
8.2. Research centers and academic & government institutes
8.3. Hospitals & Clinics
8.4. Research centers and academic & government institutes
8.5. Pharmaceutical & biotechnology companies
CHAPTER 9 GLOBAL NGS-BASED RNA SEQUENCING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL NGS-BASED RNA SEQUENCING MARKET - COMPANY PROFILES
10.1. Macrogen, Inc.
10.2. GATC Biotech.
10.3. Eurofins Scientific.
10.4. PerkinElmer, Inc.,
10.5. Oxford Nanopore Technologies Limited
10.6. Agilent Technologies, Inc.
10.7. F. Hoffmann-La Roche AG
10.8. QIAGEN
10.9. Pacific Biosciences of California, Inc.,
10.10. Thermo Fisher Scientific Inc.
10.11. Illumina, Inc.
10.12. Beijing Genomics Institute.
10.13. International Medical Group.
10.14. UnitedHealth Group Inc.
10.15. Allianz SE.
CHAPTER 11 GLOBAL NGS-BASED RNA SEQUENCING MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
